Μakoto Fujime

1.8k total citations
73 papers, 1.3k citations indexed

About

Μakoto Fujime is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Μakoto Fujime has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Μakoto Fujime's work include Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Treatment and Research (9 papers) and Urinary and Genital Oncology Studies (8 papers). Μakoto Fujime is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Treatment and Research (9 papers) and Urinary and Genital Oncology Studies (8 papers). Μakoto Fujime collaborates with scholars based in Japan, United States and Pakistan. Μakoto Fujime's co-authors include Kazuhiko Fujita, Hiroaki Shiina, Rajvir Dahiya, Mikio Igawa, Tatsuro Irimura, Shogo Ehata, Takeshi Imamura, Aki Hanyu, Toshifumi Kawakami and Kohei Miyazono and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Oncogene.

In The Last Decade

Μakoto Fujime

71 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Μakoto Fujime Japan 18 678 314 284 223 146 73 1.3k
Fabienne Escande France 22 713 1.1× 356 1.1× 267 0.9× 131 0.6× 91 0.6× 68 1.4k
Christian Kersting Germany 22 790 1.2× 294 0.9× 440 1.5× 186 0.8× 147 1.0× 42 1.6k
Norihito Soga Japan 16 611 0.9× 460 1.5× 277 1.0× 214 1.0× 108 0.7× 68 1.2k
Tsukasa Igawa Japan 16 481 0.7× 447 1.4× 278 1.0× 343 1.5× 67 0.5× 107 1.2k
F M Debruyne Netherlands 12 815 1.2× 497 1.6× 313 1.1× 289 1.3× 97 0.7× 20 1.5k
Mario Monaco Italy 22 565 0.8× 448 1.4× 273 1.0× 367 1.6× 62 0.4× 72 1.6k
Satoru Moriyama Japan 24 929 1.4× 486 1.5× 574 2.0× 238 1.1× 58 0.4× 82 1.7k
Tobias Höller Germany 22 392 0.6× 154 0.5× 319 1.1× 145 0.7× 54 0.4× 39 1.2k
Yasuo Hirono Japan 23 616 0.9× 410 1.3× 505 1.8× 525 2.4× 212 1.5× 112 1.7k
Hisashi Hasumi Japan 20 700 1.0× 697 2.2× 173 0.6× 145 0.7× 111 0.8× 73 1.4k

Countries citing papers authored by Μakoto Fujime

Since Specialization
Citations

This map shows the geographic impact of Μakoto Fujime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Μakoto Fujime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Μakoto Fujime more than expected).

Fields of papers citing papers by Μakoto Fujime

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Μakoto Fujime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Μakoto Fujime. The network helps show where Μakoto Fujime may publish in the future.

Co-authorship network of co-authors of Μakoto Fujime

This figure shows the co-authorship network connecting the top 25 collaborators of Μakoto Fujime. A scholar is included among the top collaborators of Μakoto Fujime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Μakoto Fujime. Μakoto Fujime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoki, Hiroaki, Shigehiro Soh, Ryo Sato, et al.. (2012). DIAGNOSTIC STUDY OF THE USEFULNESS OF VIRTUAL ENDOSCOPIC IMAGES AND 3-D MODELING FOR LOWER URINARY TRACT OBSTRUCTION. The Japanese Journal of Urology. 103(1). 1–7.
2.
Kazuno, Saiko, Tsutomu Fujimura, Takahiro Arai, et al.. (2011). Multi-sequential surface plasmon resonance analysis of haptoglobin–lectin complex in sera of patients with malignant and benign prostate diseases. Analytical Biochemistry. 419(2). 241–249. 23 indexed citations
3.
Ito, Yoichi M., et al.. (2008). Factors Associated with Variation in Utility Scores among Patients with Prostate Cancer. Value in Health. 11(7). 1190–1193. 17 indexed citations
4.
Ehata, Shogo, Aki Hanyu, Makoto Hayashi, et al.. (2007). Transforming Growth Factor-β Promotes Survival of Mammary Carcinoma Cells through Induction of Antiapoptotic Transcription Factor DEC1. Cancer Research. 67(20). 9694–9703. 76 indexed citations
5.
Nagao, Keiji, Yukio Itoh, Kazuhiko Fujita, & Μakoto Fujime. (2007). Evaluation of urinary CA19‐9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes. International Journal of Urology. 14(9). 795–799. 9 indexed citations
6.
7.
Fujita, Kazuhiko, Yukio Itoh, Ryo Wada, Keiji Nagao, & Μakoto Fujime. (2006). Embryonal carcinoma producing DU‐PAN‐2 with burned‐out phenomenon in the testis. International Journal of Urology. 13(4). 473–475. 6 indexed citations
8.
Ehata, Shogo, Aki Hanyu, Μakoto Fujime, et al.. (2006). Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Science. 98(1). 127–133. 146 indexed citations
9.
Katagiri, Toyomasa, Shingo Ashida, Tomoaki Fujioka, et al.. (2005). Hypoxia-Inducible Protein 2 ( HIG2 ), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy. Cancer Research. 65(11). 4817–4826. 82 indexed citations
10.
Ogishima, Tatsuya, Hiroaki Shiina, Julia E. Breault, et al.. (2005). Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 24(45). 6765–6772. 70 indexed citations
11.
Ogishima, Tatsuya, Hiroaki Shiina, Julia E. Breault, et al.. (2005). Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer. Clinical Cancer Research. 11(3). 1028–1036. 124 indexed citations
12.
Hanazawa, Kisaburo, et al.. (2005). Small cell carcinoma of the prostate with hypercalcemia. International Journal of Urology. 12(1). 108–110. 9 indexed citations
13.
Shirai, Masato, Masaki Yamanaka, Hiroaki Shiina, et al.. (2004). Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment. Urology. 64(6). 1244–1249. 14 indexed citations
14.
Matsushima, Hisashi, Kazuki Kawabe, Μakoto Fujime, et al.. (2002). Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR-Bt: A randomized controlled trial. Oncology Reports. 9(2). 283–8. 3 indexed citations
15.
Kawai, Koji, Kenzaburo Tani, Naohide Yamashita, et al.. (2002). Advanced renal cell carcinoma treated with granulocyte‐macrophage colony‐stimulating factor gene therapy: A clinical course of the first Japanese experience. International Journal of Urology. 9(8). 462–466. 7 indexed citations
16.
Hanazawa, Kisaburo, Kazuo Koizumi, Michio Tanaka, Ryota Watanabe, & Μakoto Fujime. (2000). Total Replacement of the Aorta and the Inferior Vena cava after Resection of an Extra-Adrenal Malignant Pheochromocytoma. Urologia Internationalis. 64(2). 108–110. 4 indexed citations
17.
Fujime, Μakoto, et al.. (1997). DETERMINATION OF URINARY CA19-9 LEVELS IN UROTHELIAL CANCER. The Japanese Journal of Urology. 88(3). 406–413. 7 indexed citations
18.
Morozumi, Makoto, et al.. (1997). Distal Ureteral Atresia Associated with Crossed Renal Ectopia with Fusion: Recovery of Renal Function after Release of a 10‐Year Ureteral Obstruction. International Journal of Urology. 4(5). 512–515. 6 indexed citations
19.
Fujime, Μakoto. (1995). Recent advances in the treatment of renal cell carcinoma. Juntendō Igaku. 41(3). 331–337. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabienne Escande Breakdown of academic impact, for papers by Christian Kersting Breakdown of academic impact, for papers by Norihito Soga Breakdown of academic impact, for papers by Tsukasa Igawa Breakdown of academic impact, for papers by F M Debruyne Breakdown of academic impact, for papers by Mario Monaco Breakdown of academic impact, for papers by Satoru Moriyama Breakdown of academic impact, for papers by Tobias Höller Breakdown of academic impact, for papers by Yasuo Hirono Breakdown of academic impact, for papers by Hisashi Hasumi
Rankless by CCL
2026